Ebselen protects against the reduction in levels of drug-metabolizing enzymes in livers of rats with deoxycholic acid-induced liver injury

Pharmacology and Toxicology

Volumn 91, Issue 2, 2002, Pages 64-70

  Tanaka, Masami ^a   Takezawa, Nahomi ^a   Kumai, Toshio ^a   Watanabe, Minoru ^a   Matsumoto, Naoki ^a   Nakaya, Sachiko ^a   Kobayashi, Shinichi ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 1A1; CYTOCHROME P450 3A2; DEOXYCHOLIC ACID; DRUG METABOLIZING ENZYME; EBSELEN; GLUTATHIONE PEROXIDASE; ORGANOSELENIUM DERIVATIVE; ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ANTIOXIDANT; PYRROLE DERIVATIVE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; LIPID PEROXIDATION; LIVER INJURY; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ANIMAL; ENZYMOLOGY; METABOLISM; SPRAGUE DAWLEY RAT; TOXIC HEPATITIS;

ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; ANIMAL; ANTIOXIDANTS; AZOLES; CYTOCHROME P-450 ENZYME SYSTEM; DEOXYCHOLIC ACID; HEPATITIS, TOXIC; MALE; ORGANOSELENIUM COMPOUNDS; RATS; RATS, SPRAGUE-DAWLEY; ANIMALS;

ANIMALIA;

EID: 0036667723     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0773.2002.910204.x     Document Type: Article

References (69)

1. Cholestasis induced by estradiol-17β-D-glucuronide: Mechanisms and prevention by sodium taurocholate
2. Bile acid-induced liver toxicity: Relation to the hydrophobic-hydrophilic balance of bile acids
3. Selective reduction of cis-diamminedichloroplatinum(II) nephrotoxicity by ebselen
4. Increased serum deoxycholic acid levels in men with colorectal adenomas
5. Criteria of drug-induced liver disorders report of an international consensus meeting
6. Disorders of bile acid metabolism in cholesterol gallstone disease
7. A method for the rapid determination of alkaline phosphatase with five cubic millimeters of serum
8. Effects of ebselen, a glutathioneperoxidasemimic, in several models of mitochondrial dysfunction
9. Down-regulation of male-specific cytochrome P450s 2C11 and 3A2 in bile duct-ligated male rats: Importance to reduced hepatic content of cytochrome P450 in cholestasis
10. The neuroprotective efficacy of ebselen (a glutathione peroxidase mimic) on brain damage induced by transient focal cerebral ischaemia in the rat
11. The use of highly enriched 77Se in metabolic studies of ebselen in man. An NMR investigation
12. Regulation of cholesterol and bile acid homoeostasis in bile-obstructed rats
13. Differential alterations of cytochrome P450 proteins in livers from patients with severe chronic liver disease
14. Serum bile acid concentration in some experimental liver lesions of rat
15. Determination of bile acids in needle biopsies of human liver
16. Conjugates of ursodeoxycholate protect against toxicity of more hydrophobic bile salts: In vitro studies in rat hepatocytes and human erythrocytes
17. Conjugates of ursodeoxycholate protect against cholestasis and hepatocellular necrosis caused by more hydrophobic bile salts: In vivo studies in the rat
18. Ursodeoxycholic acid for primary biliary cirrhosis
19. Bile acid hepatotoxicity and the rationale of UDCA therapy in chronic cholestatic liver disease; Some hypotheses
20. Tauroursodeoxycholate prevents biliary protein excretion induced by other bile salts
21. Ebselen prevents early alcohol-induced liver injury in rats
22. Expression of antigens related to apoptosis and cell proliferation in chronic nonsuppurative destructive cholangitis in primary biliary cirrhosis
23. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
24. Ursodeoxycholic acid in primary biliary cirrhosis; Results of a controlled double-blind trial
25. Mechanism of protection of ebselen against paracetamol-induced toxicity in rat hepatocytes
26. Cytoprotection with ursodeoxycholic acid: Effect in chronic non-cholestatic and chronic cholestatic liver disease
27. Effect of deoxycholic acid and ursodeoxycholic acid on lipid peroxidation in cultured macrophages
28. Protein measurement with the folin phenol reagent
29. Improvement of biliary enzyme levels and itching as a result of long-term administration of ursodeoxycholic acid in primary biliary cirrhosis
30. Modification of ion homeostasis by lipid peroxidation: Roles in neuronal degeneration and adaptive plasticity
31. Characterization of cholestasis induced by estradiol-17β-D-glucuronide in the rat
32. Effect of chenodeoxycholic and ursodeoxycholic acids on isolated adult human hepatocytes
33. A novel biologically active selenoorganic compound-IV. Protective glutathione-dependent effect of PZ 51 (ebselen) against ADP-Fe induced liver peroxidation in isolated hepatocytes
34. Impaired expression of microsomal cytochrome P450 2C11 in choline-deficient rat liver during the development of cirrhosis
35. Antioxidant activity of ebselen and related selenoorganic compounds in microsomal lipid peroxidation
36. Mechanism of liver mitochondrial dysfunction associated with bile duct obstruction
37. Microsomal and peroxisomal fatty acid oxidation in bile duct ligated rats: A comparative study between liver and kidney
38. Effect of ursodeoxycholic acid in chronic hepatitis and primary biliary cirrhosis
39. Ebselen, a novel anti-oxidant compound, protects the rat liver from ischemia-reperfusion injury
40. Seleno-organic compounds and the therapy of hydroperoxide-linked pathological conditions
41. Selenoorganic therapy of inflammation
42. Microsomal fraction in biliary obstructed rats
43. Increases of intracellular magnesium promote glycodeoxycholate-induced apoptosis in rat hepatocytes
44. Is ursodeoxycholic an effective treatment for primary biliary cirrhosis?
45. Ursodeoxycholic acid for the treatment of primary biliary cirrhosis; Interim analysis of a double-blind multicenter randomized trial
46. A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic trans-aminases
47. The CYP2E subfamily
48. Effects of chlorpromazine hydrochloride on bile salt synthesis, bile formation and biliary lipid secretion in the rhesus monkey: A model for chlorpromazine-induced cholestasis
49. Protection against hydrophobic bile salt-induced cell membrane damage by liposomes and hydrophilic bile salts
50. Neuroprotective effect of an antioxidant, ebselen, in patients with delayed neurological deficits after aneurismal subsrachnoid hemorrhage
51. Reactivity of ebselen and related selenoorganic compounds with 1,2-dichloroethane radical cations and halogenated peroxyl radicals
52. Influence of hydroxylation and conjugation of bile salts on their membrane damaging properties: Studies on isolated hepatocyte and lipid membrane vesicles
53. Regulation of bile acid synthesis by deoxycholic acid in the rat: Different effects on cholesterol 7α-hydroxylase and sterol 27-hydroxylase
54. Ebselen, a selenoorganic compound as glutathione peroxidase mimic
55. Evidence for involvement of oxygen free radicals in bile acid toxicity to isolated rat hepatocyte
56. Generation of hydroperoxides in isolated rat hepatocytes and hepatic mitochondria exposed to hydrophobic bile acids
57. Vitamin E reduces oxidant injury to mitochondria and the hepatotoxicity of taurochenodeoxycholic acid in the rat
58. Liver transplantation
59. Partitioning of bile acids into subcellular organelles and the in vivo distribution of bile acids in rat liver
60. Neuroprotective efficacy of ebselen, an antioxidant with anti-inflammatory actions, in a rodent model of permanent middle cerebral artery occlusion
61. Ursodeoxycholic acid prevents hepatic cytochrome P450 isozyme reduction in rats with deoxycholic acid-induced liver injury
62. Liver damage induced by bile duct ligation affects CYP isoenzymes differently in rats
63. Taurine conjugate of ursodeoxycholate plays a majour role in the hepatoprotective effect against cholestasis induced by taurocholate in rats
64. Reversible bile acid changes in bile duct obstruction and its potential for hepatocellular injury
65. Liver transplantation in pediatrics: Indications, contraindications and pretransplant management
66. Deterioration of primary biliary cirrhosis during treatment with ursodeoxycholic acid
67. Protective effect of ebselen against hydrogen peroxide-induced cytotoxicity and DNA damage in HepG2 cells
68. 1-induced hepatocarcinogenesis in Fischer 344 rats
69. Bile acid-induced rat hepatocyte apoptosis is inhibited by antioxidants and blockers of the mitochondrial permeability transition